Erratum: Anti-tuberculosis drug resistance in Bangladesh: Reflections from the first nationwide survey (Int J Tuberc Lung Dis (2015) 19:2 (151-156) 10.5588/ijtld.14.0200);Anti-tuberculosis drug resistance in Bangladesh: Reflections from the first nationwide survey

International Journal of Tuberculosis and Lung Disease

Volumn 19, Issue 2, 2015, Pages 151-156

  Kamal, S M M ^a   Hossain, Md A ^b   Sultana, S ^c   Begum, V ^d   Haque, N ^b   Ahmed, Md J ^e   Rahman, T M A ^f   Hyder, Md K A ^g   Hossain, Md S ^a   Rahman, M ^e   Chowdhury, R A ^h   Aung, K J M ⁱ   Islam, Md A ^j   Hasan, Md R ^k   Van Deun, A ^l  

^a National Institute of Diseases of the Chest and Hospital (NIDCH)   (Bangladesh)

^b MINISTRY OF HEALTH AND FAMILY WELFARE   (Bangladesh)

^c WORLD HEALTH ORGANIZATION   (Switzerland)

^d WHO   (Bangladesh)

^e Tuberculosis CARE II University Research Company   (Bangladesh)

^f Bangladesh Unnayan Parishad   (Bangladesh)

^g WHO South East Asia Regional Office ^*  (India)

^h UNIVERSITY OF DHAKA   (Bangladesh)

ⁱ Damien Foundation   (Bangladesh)

^j RESEARCH AND EVALUATION DIVISION   (Bangladesh)

^k NIDCH   (Bangladesh)

^l INSTITUTE OF TROPICAL MEDICINE   (Belgium)

more..

Author keywords

Bangladesh; Drug resistance; Prevalence; Survey; Tuberculosis

Indexed keywords

DIHYDROSTREPTOMYCIN; ETHAMBUTOL; ISONIAZID; KANAMYCIN; OFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFAMPICIN; TUBERCULOSTATIC AGENT; QUINOLONE DERIVATIVE;

ADOLESCENT; ADULT; AGED; ANTIBIOTIC SENSITIVITY; BACTERIAL STRAIN; BACTERIUM CULTURE; BANGLADESH; CLUSTER ANALYSIS; CROSS-SECTIONAL STUDY; CULTURE MEDIUM; DISEASE TRANSMISSION; DRUG TREATMENT FAILURE; FEMALE; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; MIDDLE AGED; MULTIDRUG RESISTANT TUBERCULOSIS; MYCOBACTERIUM TUBERCULOSIS; PREDICTION; PREVALENCE; PRIORITY JOURNAL; RELAPSE; REVIEW; SPUTUM SMEAR; TUBERCULOSIS; YOUNG ADULT; DRUG EFFECTS; ISOLATION AND PURIFICATION; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; MULTIDRUG RESISTANCE; SPUTUM; TRANSMISSION; TUBERCULOSIS, MULTIDRUG-RESISTANT;

ADOLESCENT; ADULT; AGED; ANTITUBERCULAR AGENTS; BANGLADESH; CROSS-SECTIONAL STUDIES; DRUG RESISTANCE, MULTIPLE, BACTERIAL; FEMALE; FLUOROQUINOLONES; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; PREVALENCE; SPUTUM; TUBERCULOSIS, MULTIDRUG-RESISTANT; YOUNG ADULT;

EID: 84937117971     PISSN: 10273719     EISSN: 18157920     Source Type: Journal    
DOI: 10.5588/ijtld.14.0200-e     Document Type: Erratum

References (12)

1. World Health Organization. Global tuberculosis report 2012. WHO/HTM/TB/2012.6. Geneva, Switzerland: WHO, 2012.
2. Van Deun A, Salim A H, Daru P, et al. Drug resistance monitoring: combined rates may be the best indicator of programme performance. Int J Tuberc Lung Dis 2004; 8: 23-30.
3. Zaman K, Rahim Z, Yunus M, et al. Drug resistance of Mycobacterium tuberculosis in selected urban and rural areas of Bangladesh. Scand J Infect Dis 2005; 37: 21-26.
4. World Health Organization. Guidelines for surveillance of drug resistance in tuberculosis. 4th ed. WHO/HTM/TB/2009.422. Geneva, Switzerland: WHO, 2009.
5. World Health Organization. Treatment of tuberculosis: guidelines for national programmes. 4th ed. WHO/HTM/TB/2009.420. Geneva, Switzerland: WHO, 2010.
6. Petroff S A. A new and rapid method for the isolation and cultivation of tubercle bacilli directly from the sputum and feces. J Exp Med 1915; 21: 38-42.
7. Canetti G, FoxW, Khomenko A, MitchisonD A, Rist N, Smelev N A. Advances in techniques of testing mycobacterial drug sensitivity, and the use of sensitivity tests in tuberculosis control programmes. Bull World Health Organ 1969; 41: 21-43.
8. World Health Organization. The WHO/IUATLD Global Project on Anti-Tuberculosis Drug Resistance Surveillance. Anti-tuberculosis drug resistance in the world. Report No. 4. WHO/HTM/TB/2008.394. Geneva, Switzerland: WHO, 2008;
9. Affolabi D, Adjagba O A, Tanimomo-Kledjo B, Gninafon M, Anagonou S Y, Portaels F. Anti-tuberculosis drug resistance among new and previously treated pulmonary tuberculosis patients in Cotonou, Benin. Int J Tuberc Lung Dis 2007; 11: 1221-1224.
10. Chonde T M, Basra D, Mfinanga S G M, et al. National antituberculosis drug resistance study in Tanzania. Int J Tuberc Lung Dis 2010; 14: 967-972.
11. Van Deun A, Hamid Salim A, Rigouts L, Rahman M, Fissette K, Portaels F. Evaluation of tuberculosis control by periodic or routine susceptibility testing in previously treated cases. Int J Tuberc Lung Dis 2001; 5: 329-338.
12. van Rie A, Warren R, Richardson M, et al. Classification of drug-resistant tuberculosis in an epidemic area. Lancet 2000; 356: 22-25.